Effect of Recombinant Human Granulocyte Colony- Stimulating Factor on CD11b in Septic Neonates
NCT01479114 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2011-11-28
Summary
The investigators aimed to evaluate the effect of G-CSF administration in septic neonates on neutrophil production and CD11b expression.
Conditions
- Neonatal Sepsis
Interventions
- DRUG
-
rh-GCSF
10 ug/kg/day intravenously for 3 days
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Max Age
- 4 Weeks
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2010-05-31
- Completion
- 2010-05-31
More Related Trials
-
Immunomodulatory Properties of Ketamine in Sepsis
NCT01089361 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis
NCT03280147 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Outcome With Antibiotic Use and Its Resistance Pattern Among Patient With Neonatal Sepsis
NCT05742477 ·Status: UNKNOWN
-
GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia
NCT04569877 ·Status: COMPLETED ·Phase: PHASE2
-
Neutrophil Phenotypic Profiling and Organ Injury Assessment in Patients With Sepsis
NCT04103268 ·Status: RECRUITING
-
Procalcitonin-Guided Decision Making to Shorten Antibiotic Therapy in Suspected Neonatal Early-Onset Sepsis
NCT00926497 ·Status: COMPLETED ·Phase: NA
-
Analysis of Differential Proteins and Maternal Influencing Factors of Septic Shock in Neonates
NCT06206590 ·Status: RECRUITING
-
Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'
NCT01006499 ·Status: UNKNOWN ·Phase: PHASE4
-
GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults
NCT00089986 ·Status: COMPLETED ·Phase: PHASE2
-
Study and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral Sepsis
NCT06657781 ·Status: RECRUITING
-
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
NCT04117568 ·Status: TERMINATED
-
Cytokine Response in Septic Shock
NCT01770457 ·Status: UNKNOWN
-
Neonatal Procalcitonin Intervention Study
NCT00854932 ·Status: UNKNOWN ·Phase: NA
-
Zinc Supplementation in Pediatric Sepsis
NCT05366595 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Inflammatory Markers in Sepsis
NCT06111963 ·Status: COMPLETED
-
Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children
NCT00118664 ·Status: COMPLETED
-
The Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing Hemofiltration
NCT06994312 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Frequency and Severity of Thrombocytopenia in Neonatal Sepsis
NCT05692128 ·Status: UNKNOWN
-
Pharmacokinetics and Pharmacodynamics of Ceftazidime in Pediatric ICU Patients
NCT03133910 ·Status: UNKNOWN
-
EFFICACY OF PROLONGED INFUSION MEROPENEM IN CRITICALLY ILL PAEDIATRIC INTENSIVE CARE PATIENTS
NCT07122596 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.
NCT05953142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Outcome of Using Hydrocortisone in Early Treatment of Pediatric Septic Shock
NCT07313670 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Neutrophil FFA2/GPR43 Receptor Expression in Patients With the Diagnosis of Sepsis
NCT02699905 ·Status: WITHDRAWN
-
Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Congenital Heart Disease
NCT03923543 ·Status: COMPLETED
-
Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis
NCT06626984 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2